GB8711058D0 - Combination - Google Patents

Combination

Info

Publication number
GB8711058D0
GB8711058D0 GB878711058A GB8711058A GB8711058D0 GB 8711058 D0 GB8711058 D0 GB 8711058D0 GB 878711058 A GB878711058 A GB 878711058A GB 8711058 A GB8711058 A GB 8711058A GB 8711058 D0 GB8711058 D0 GB 8711058D0
Authority
GB
United Kingdom
Prior art keywords
tissue
medicament
damage
combination
jeopardised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB878711058A
Other versions
GB2194886B (en
GB2194886A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/862,057 external-priority patent/US4976959A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of GB8711058D0 publication Critical patent/GB8711058D0/en
Publication of GB2194886A publication Critical patent/GB2194886A/en
Application granted granted Critical
Publication of GB2194886B publication Critical patent/GB2194886B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Tissue plasminogen activator (t-PA), optionally together with superoxide dismutase (SOD), is used to manufacture a medicament for use in the inhibition of damage to jeopardised tissue during blood reperfusion. The medicament is for preventing damage to tissue following ischaemic attack, e.g. in myocardial tissue, when blood supply is restored.
GB8711058A 1986-05-12 1987-05-11 Medicaments containing tissue plasminogen activator. Expired - Fee Related GB2194886B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86204686A 1986-05-12 1986-05-12
US06/862,057 US4976959A (en) 1986-05-12 1986-05-12 T-PA and SOD in limiting tissue damage

Publications (3)

Publication Number Publication Date
GB8711058D0 true GB8711058D0 (en) 1987-06-17
GB2194886A GB2194886A (en) 1988-03-23
GB2194886B GB2194886B (en) 1990-04-25

Family

ID=27127662

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8711058A Expired - Fee Related GB2194886B (en) 1986-05-12 1987-05-11 Medicaments containing tissue plasminogen activator.

Country Status (13)

Country Link
JP (1) JPH0680015B2 (en)
AU (1) AU600724B2 (en)
BE (1) BE1001425A4 (en)
CH (1) CH672989A5 (en)
DE (1) DE3715662A1 (en)
DK (1) DK237187A (en)
FR (1) FR2600895B1 (en)
GB (1) GB2194886B (en)
IE (1) IE59895B1 (en)
LU (1) LU86875A1 (en)
NL (1) NL8701113A (en)
NZ (1) NZ220260A (en)
SE (1) SE8701921L (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0780784B2 (en) * 1987-10-23 1995-08-30 宇部興産株式会社 Myocardial ischemic injury therapeutic agent based on microcirculatory disorder
NZ230808A (en) * 1988-10-24 1993-04-28 Squibb & Sons Inc Pharmaceutical compositions and combinations containing an angiotensin-converting enzyme inhibitor and a thrombolytic agent
DE4038563A1 (en) * 1990-12-04 1992-06-11 Gruenenthal Gmbh USE OF SUPEROXIDE DISMUTASES FOR PROPHYLAXIS AND / OR TREATMENT OF ORGAN FAILURE IN RISK PATIENTS WITH POLYTRAUMA
DE19518625C2 (en) * 1995-05-24 1997-08-07 Buescher Pebueso Beton Process for sealing concrete pipes and a concrete pipe suitable for carrying out the process
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7517529B2 (en) 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
JP4846799B2 (en) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． Tumor treatment
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US8652476B2 (en) 2009-07-27 2014-02-18 Niigata University Pharmaceutical composition for treating ischemic events
WO2011013668A1 (en) * 2009-07-27 2011-02-03 国立大学法人新潟大学 Pharmaceutical composition for treatment of ischemic events
US10617756B2 (en) 2017-01-05 2020-04-14 Shimojani, LLC Drug regimen for treatment of cerebral ischemia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003402A (en) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw NEW PLASMINOGEN ACTIVATOR AND PHARMACEUTICAL PREPARATION WITH THROMBOLYTIC ACTION.
EP0112122B1 (en) * 1982-12-14 1991-08-28 South African Inventions Development Corporation Plasminogen activator
JPS59196824A (en) * 1983-04-21 1984-11-08 Kowa Co Adsorption inhibitor
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
NL8601354A (en) * 1985-05-28 1986-12-16 Wellcome Found NEW COMPOSITION.
WO1987006831A1 (en) * 1986-05-15 1987-11-19 Emory University Composition and method for treating a thrombus and embolus

Also Published As

Publication number Publication date
JPH0680015B2 (en) 1994-10-12
FR2600895A1 (en) 1988-01-08
LU86875A1 (en) 1988-01-20
BE1001425A4 (en) 1989-10-31
IE59895B1 (en) 1994-04-20
FR2600895B1 (en) 1993-12-24
NL8701113A (en) 1987-12-01
IE871210L (en) 1987-11-12
DE3715662A1 (en) 1987-11-19
AU600724B2 (en) 1990-08-23
JPS6322026A (en) 1988-01-29
NZ220260A (en) 1990-07-26
DK237187D0 (en) 1987-05-11
DK237187A (en) 1987-11-13
SE8701921D0 (en) 1987-05-11
GB2194886B (en) 1990-04-25
GB2194886A (en) 1988-03-23
AU7270487A (en) 1987-11-19
CH672989A5 (en) 1990-01-31
SE8701921L (en) 1987-11-13

Similar Documents

Publication Publication Date Title
GB8711058D0 (en) Combination
ATE172359T1 (en) COLD STERILIZER WITH EXTENDED ACTIVITY
AU687112B2 (en) Methods for increasing extracellular adenosine and for stabilization mast cells
GB8822147D0 (en) Pharmaceutically active combination
ZA791797B (en) Use of antioestrogens and antigonadotropically active antiandrogens for the prophylaxis and therapy of prostate hyperplasia
TW250435B (en)
NZ514663A (en) Indigoid bisindole derivatives for treating solid cancers
DK0506791T3 (en) Enzyme-containing preparation and detergent containing such preparation
EP0480906A3 (en) Pharmaceutical preparation on basis of lys-plasminogen
AU6414498A (en) Composition comprising immunoglobulin
GR3034237T3 (en) Process to prepare a cetrorelix lyophilised composition.
GR3034946T3 (en) Preparation of factor ix.
IL90146A0 (en) Variants of plasminogen activators and processes for their production
GR3017321T3 (en) Use of amino acids for the protection of and metabolic recovery of ischemic cardiac tissue.
ES2162433T3 (en) PROCEDURE FOR THE TREATMENT OF THE CEMENT CLINKER.
SE9602644D0 (en) New use
ES2000033A6 (en) Liquid stable anthelmintic and fungicidal composition based on bithionol sulfoxide.
EP0208785A4 (en) Fibrinophilic urokinase complex and process for its preparation.
GR3036481T3 (en) Medicament containing delta-aminolevulinic acid
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
AU6997287A (en) The application of tissue plasminogen activator and oxypurinol in dissolving blood clots and in preventing damage to ischaemic tissue during reperfusion
KR890701732A (en) Improved tissue plasminogen activator
IL101854A (en) Container adapted to be used as a toy
GR77250B (en)
IT1206281B (en) Tissue plasminogen activator to remove blood clots

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960511

732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)